These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3109750)

  • 1. Sensitivity to rifaximin and rifampicin of Mycobacterium tuberculosis isolated from guinea pigs treated orally with rifaximin.
    Malvisi Stracciari J; Venturini AP; Anfossi P; Marchi E; Stracciari GL
    Chemioterapia; 1987 Apr; 6(2):82-4. PubMed ID: 3109750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimycobacterial activity of rifaximin (L/105) in experimental tuberculosis in the guinea pig.
    Lucchesi M; Marchi E; Venturini AP
    Chemioterapia; 1984 Dec; 3(6):371-2. PubMed ID: 6442216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The animal experimental study on rifampicin-dependent Mycobacterium tuberculosis].
    Li YL; Luo YA; Zhong M; Chen BW; Shen XB; Su C; Wang GZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):617-21. PubMed ID: 17129470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of the spiropiperidyl rifamycin LM 427 on rifampicin resistant Mycobacterium tuberculosis.
    Ungheri D; Della Bruna C; Sanfilippo A
    G Ital Chemioter; 1984; 31(3):211-4. PubMed ID: 6100178
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.
    Dickinson JM; Mitchison DA
    Tubercle; 1987 Sep; 68(3):177-82. PubMed ID: 2834842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].
    Saito H; Sato K; Tomioka H
    Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin-susceptibility and rifampicin-resistance in mycobacteria.
    Manten A; van Wijngaarden LJ; van Klingeren B
    Acta Tuberc Pneumol Belg; 1969; 60(3):329-34. PubMed ID: 4984415
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
    Woodley CL; Kilburn JO
    Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathomorphology of experimental tuberculosis induced by rifampicin-resistant mycobacteria].
    Vidin NB; El'shanskaia MP
    Probl Tuberk; 1972; 50(7):63-7. PubMed ID: 4626207
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rifampicin resistence and virulence of M. tuberculosis for guinea pigs].
    Schröder KH; Koperska C
    Zentralbl Bakteriol Orig A; 1972 Jan; 219(1):112-3. PubMed ID: 4402403
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimycobacterial activity of rifampicin.
    Lucchesi M; Mancini P
    Antibiot Chemother; 1970; 16():431-43. PubMed ID: 5002307
    [No Abstract]   [Full Text] [Related]  

  • 14. Suitability of rifampicin for intermittent administration in the treatment of tuberculosis.
    Dickinson JM; Mitchison DA
    Tubercle; 1970 Mar; 51(1):82-94. PubMed ID: 4992976
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biological characteristics of rifampicin-resistant Mycobacterium tuberculosis].
    Klimenko MT
    Antibiotiki; 1984 Mar; 29(3):185-8. PubMed ID: 6428304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Virulence of rifampicin-resistent Mycobacterium tuberculosis].
    Klimenko MT
    Probl Tuberk; 1978 Jun; (6):73-7. PubMed ID: 97662
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro activity of rifaximin and rifampicin against some anaerobic bacteria.
    Lamanna A; Orsi A
    Chemioterapia; 1984 Dec; 3(6):365-7. PubMed ID: 6529778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse].
    Grosset J; Truffot-Pernot C; Poggi S; Lecoeur H; Chastang C
    Rev Mal Respir; 1985; 2(4):205-8. PubMed ID: 3937188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-resistance between rifampicin and KRM-1648 is associated with specific rpoB alleles in Mycobacterium tuberculosis.
    Park YK; Kim BJ; Ryu S; Kook YH; Choe YK; Bai GH; Kim SJ
    Int J Tuberc Lung Dis; 2002 Feb; 6(2):166-70. PubMed ID: 11931418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The virulence of Mycobacterium tuberculosis strains resistant to rifampicin. (Preliminary note)].
    Daddi G; Lucchesi M; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(1):29-33. PubMed ID: 4996681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.